Use the future to build the present
Olaf Blanke
Comment
Stakeholder Type
,
1Quantum Revolution& Advanced AI2HumanAugmentation3Eco-Regeneration& Geo-Engineering4Science& Diplomacy1.11.21.31.42.12.22.32.43.13.23.33.43.54.14.24.34.44.5HIGHEST ANTICIPATIONPOTENTIALAdvancedArtificial IntelligenceQuantumTechnologiesBrain-inspiredComputingBiologicalComputingCognitiveEnhancementHuman Applications of Genetic EngineeringRadical HealthExtensionConsciousnessAugmentation DecarbonisationWorldSimulationFuture FoodSystemsSpaceResourcesOceanStewardshipComplex Systems forSocial EnhancementScience-basedDiplomacyInnovationsin EducationSustainableEconomicsCollaborativeScience Diplomacy
1Quantum Revolution& Advanced AI2HumanAugmentation3Eco-Regeneration& Geo-Engineering4Science& Diplomacy1.11.21.31.42.12.22.32.43.13.23.33.43.54.14.24.34.44.5HIGHEST ANTICIPATIONPOTENTIALAdvancedArtificial IntelligenceQuantumTechnologiesBrain-inspiredComputingBiologicalComputingCognitiveEnhancementHuman Applications of Genetic EngineeringRadical HealthExtensionConsciousnessAugmentation DecarbonisationWorldSimulationFuture FoodSystemsSpaceResourcesOceanStewardshipComplex Systems forSocial EnhancementScience-basedDiplomacyInnovationsin EducationSustainableEconomicsCollaborativeScience Diplomacy

Profile:

Olaf Blanke

Bertarelli Foundation Chair of Cognitive NeuroprostheticsEPFL

Olaf Blanke is Bertarelli Foundation Chair of Cognitive Neuroprosthetics at the Swiss Federal Institute of Technology (EPFL), where he directs the Laboratory of Cognitive Neuroscience at Geneva’s Campus Biotech.

He founded and directed EPFL’s Center for Neuroprosthetics (2012-2018) and is Professor at Geneva University Hospital. Blanke’s research focuses on the neuroscience of consciousness and embodiment, human augmentation and personalized medicine. Blanke pioneered the development and integration of robotic and virtual reality technology in neuroscience of consciousness studies and cognitive research. His medical activities are dedicated to the application of these innovations to novel diagnostic and therapeutic procedures in neurodegeneration and cognitive decline (Parkinson’s disease, dementia), as well as in well-being and mental health.